<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-75048</identifier>
<setSpec>0304-5013</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Low maternal free thyroxine concentrations during pregnancy is associated with attention-deficit/hyperactivity disorder</dc:title>
<dc:description xml:lang="en">Objective: To investigate the relationship between ADHD test scores in children and mothers who had low levels of thyroxine while pregnant. Material and methods: A total of 59 women and their children were included in the study. In 28 of them a free thyroxine (FT4) lower than the percentile 10 of normal pregnancy values was detected in the third trimester of gestation. The control group (n = 30) was selected randomly from 442 pregnant women from an original cohort having normal FT4 values using the SPSS program. The ADHD test was administered to the mothers by a trained interviewer and a score was obtained covering two different dimensions, one on attention and the other related to hyperactivity impulsivity. Results: Children of mothers with gestational hypothyroxinaemia had an average of 7.3 more points in the ADHD global score (95% CI,2.6-12.05, P=.003). For the attention scale this revi difference was 2.2 (95% CI, 0.33-4.05, P=.022), and for hyperactivity-impulsivity it was 5.1 points (95%CI, 1.4-8.9, P=.008). Logistic regression analysis showed that the offspring of mothers with gestational hypothyroxinaemia had an adjusted odds ratio of 3.9 (95% CI, 1.1-14.2, P=.036) of having an abnormal ADHD test score. Conclusion: Low maternal FT4 in third trimester of gestation is associated with abnormal ADHD scores and a significant risk of ADHD in the offspring. Appropriate correction of gestational hypothyroxinaemia by means of sufficient iodine supply in the preconception period or thyroxine supplementation very early in pregnancy may prevent future development of ADHD in the progeny (AU)</dc:description>
<dc:creator>Puig, Manel</dc:creator>
<dc:creator>Muñoz, Míriam</dc:creator>
<dc:creator>Figueras, Francesc</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: El objetivo de este estudio es determinar si existe una relación entre la aparición del trastorno de hiperactividad y déficit de atención(THDA) y la hipotiroxinemia durante la gestación. Material y métodos: Se seleccionó a 59 pacientes con determinaciones de FT4 en el tercer trimestre de la gestación, entre los 15 meses y los 2 años después del parto. De estas mujeres, 34 tenían valores &lt; 0,79 ng/dl (que es el percentil 10 de la distribución de T4 en gestantes normoyodadas de nuestra área).Se interrogó a la madre sobre la presencia de los18 síntomas que constituyen la prueba de HTDA. Las respuestas obtenidas se transformaron en una puntuación dependiendo de la frecuencia de aparición de los citados síntomas. Resultados: Tener una T4 anormal implica demedia 6,7 (intervalo de confianza [IC] del 95%,1,75-11,58) puntos más de la escala y esta diferencia resultó significativa (p = 0,009).Conclusión: Parece existir una relación positiva entre la hipotiroxinemia gestacional y una frecuencia aumentada en la aparición de síntomas de HTDA, aunque el diagnóstico del trastorno debería realizarlo un profesional cualificado (AU)</dc:description>
<dc:source>Prog. obstet. ginecol. (Ed. impr.);52(12): 681-685, dic. 2009. tab</dc:source>
<dc:identifier>ibc-75048</dc:identifier>
<dc:title xml:lang="es">La hipotiroxinemia gestacional se asocia al síndrome de déficit de atención e hiperactividad</dc:title>
<dc:subject>^d1295^s22012</dc:subject>
<dc:subject>^d22261</dc:subject>
<dc:subject>^d1295^s22016</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d14360^s22002</dc:subject>
<dc:subject>^d19196^s22012</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d11688^s22016</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d24772</dc:subject>
<dc:subject>^d24584</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d19196^s22016</dc:subject>
<dc:subject>^d11688^s22044</dc:subject>
<dc:subject>^d14344^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>200912</dc:date>
</metadata>
</record>
</ibecs-document>
